Wellfully (ASX:WFLOA) OCF Yield %: 0.00 (As of Jul. 02, 2026)


What is Wellfully OCF Yield %?

Wellfully ASX:WFLOA OCF Yield % is 0.00 as of Jul. 02, 2026. The stock has 7 warning signs investors should review.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Wellfully's Trailing 12-Month Cash Flow from Operations is A$-0.02 Mil, and Market Cap is A$0.00 Mil. Therefore, Wellfully's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Wellfully's OCF Yield % or its related term are showing as below:


ASX:WFLOA's OCF Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.02
* Ranked among companies with meaningful OCF Yield % only.

Wellfully's OCF Margin % for the quarter that ended in Dec. 2023 was %.

Wellfully OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Wellfully OCF Yield % Related Terms

Wellfully OCF Yield % Historical Data

* Premium members only.

The historical data trend for Wellfully's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wellfully OCF Yield % Chart

Wellfully Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wellfully Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wellfully OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Wellfully's OCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-2.443 /
=N/A%

Wellfully's annualized OCF Yield % for the quarter that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0.028 * 2 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Wellfully (ASX:WFLOA) has a OCF Yield % of 0.00 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Wellfully and its competitors.
Is Wellfully's OCF Yield % too high?
Wellfully's current OCF Yield % is 0.00.
How does Wellfully's OCF Yield % compare to TMO and DHR?
Wellfully's OCF Yield % of 0.00 can be compared against companies in the Medical Diagnostics & Research industry. The industry median OCF Yield % is 1.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.02, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Wellfully and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellfully's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellfully stock overvalued right now?
Wellfully (ASX:WFLOA) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Wellfully (ASX:WFLOA), the current OCF Yield % is 0.00 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellfully Business Description

Address 284 Oxford Street, Ground Floor, Leederville, WA, AUS, 6007
Wellfully Ltd is engaged in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates in segments namely the development of the dermaportation drug delivery technology and Devices segments. Geographically, it derives a majority of its revenue from Europe and also has a presence in Japan. It serves the Pharmaceutical; Cosmetics Skincare and Consumer Healthcare industries.